An Unusual Metastatic Motilin-Secreting Neuroendocrine Tumour with a 20-Year Survival

Motilin-secreting neuroendocrine tumours have been rarely described. Immunohistochemical, biochemical and motility investigations were performed in a 62-year-old man with liver and bone metastases of a motilin-secreting neuroendocrine tumour originating from a rectal polyp removed 14 years previously. Symptoms related to liver metastases were reduced by a right hepatectomy whereas plasma motilin levels were decreased. The patient also underwent two operations for spinal cord decompression and survived 6 more years under medical treatment, mainly octreotide. Immunohistochemistry revealed predominant expression of motilin-containing cells, with rare cells expressing somatostatin and pancreatic polypeptide, and staining for only one panendocrine marker, neurone-specific enolase. A liver tumour extract contained 17.9 µg motilin per gram of tissue, which permitted to isolate and characterize human motilin, which was identical to porcine motilin. Plasma column gel chromatography revealed a main peak corresponding apparently to porcine motilin. The patient had no symptoms of disturbed motility. Gastric emptying and gastroduodenojejunal motility were found within normal limits. The absence of alterations of gut motility was perhaps related to sustained autonomous motilin production. The long evolution of this type of tumour suggests that plasma motilin determination should be added to the investigations for neuroendocrine tumours.

[1]  B. Weynand,et al.  Motilin-producing liver and bone metastases evidenced 14 years after resection of a rectal polyp. , 1999, The American journal of surgical pathology.

[2]  G. Assche,et al.  Purification and amino acid sequence of human motilin isolated from a motilin containing liver metastasis , 1995, Regulatory Peptides.

[3]  T. Saclarides,et al.  Neuroendocrine cancers of the colon and rectum , 1994, Diseases of the colon and rectum.

[4]  R. Ekman,et al.  Disseminated rectal carcinoid tumor with production of immunoreactive motilin , 1992, Endocrine Pathology.

[5]  J. Ray,et al.  Rectal carcinoids: The most frequent carcinoid tumor , 1992, Diseases of the colon and rectum.

[6]  I. Depoortere,et al.  Effect of erythromycin and of octreotide on motilin receptor density in the rabbit , 1991, Regulatory Peptides.

[7]  E. Zimmerman,et al.  Characterization of complementary deoxyribonucleic acid for precursor of porcine motilin. , 1988, Molecular endocrinology.

[8]  K. Oberg,et al.  Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements. , 1987, Scandinavian journal of gastroenterology.

[9]  K. Tanaka,et al.  Sequence of an intestinal cDNA encoding human motilin precursor , 1987, FEBS letters.

[10]  P. Rocmans,et al.  Increased plasma motilin concentrations in small cell carcinoma of the lung. , 1987, Thorax.

[11]  S. Bloom,et al.  Chromatographic analysis of plasma motilin immunoreactivity in human disease using region specific antibodies. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[12]  G. Vantrappen,et al.  Fasting plasma motilin levels are related to the interdigestive motility complex. , 1980, Gastroenterology.

[13]  E. Hashimura,et al.  Heterogeneity of Plasma Motilin in Patients with Chronic Renal Failure , 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  S. Bloom,et al.  PLASMA-MOTILIN IN CARCINOID TUMOURS , 1977, The Lancet.

[15]  R. Arnold,et al.  Control of growth in neuroendocrine gastro-enteropancreatic tumours. , 1996, Digestion.

[16]  K. Oberg.  Biological aspects of neuroendocrine gastro-enteropancreatic tumours. , 1996, Digestion.

[17]  W. Creutzfeldt,et al.  Historical background and natural history of carcinoids. , 1994, Digestion.

[18]  J. Norton,et al.  Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. , 1994, Digestion.

[19]  H. Höfler,et al.  Revised classification of neuroendocrine tumors of the lung, pancreas and gut. , 1994, Digestion.

[20]  G. Hanique,et al.  24 Hr Ambulatory Gastrointestinal Manometry - a Reliable and Well Tolerated Procedure , 1993 .

[21]  J. Polak,et al.  Molecular forms of motilin in the mammalian and human gut and human plasma. , 1981, Gastroenterology.